The injectable drug delivery industry focuses on methods for administering medications through injections, ensuring timely and effective treatment. It includes companies that design devices, develop formulations, and offer manufacturing services for injectables. With advances in technology, there's a growing trend towards personalized medicine, smart delivery systems, and patient-friendly devices that enhance adherence to treatment regimens. Biologics and advanced therapeutics are on the rise, indicating a shift towards complex drug formulations. As healthcare demands evolve, innovation in injectable systems could significantly enhance treatment efficacy and patient experiences, making the industry a focal point for future pharmaceutical development.

The listed companies represent a mix of sizes and specializations, with many established in the last two decades. They hail from various regions, including Europe and North America. Companies like Pharmathen and Antares Pharma focus on advanced drug delivery technologies for injectables, while others excel in device manufacturing. Often, these firms collaborate with pharmaceutical giants to deliver innovative solutions. The breadth of expertise ranges from device design to complex formulation development, positioning them well for future advancements in the healthcare sector.

Continue reading to discover the top injectable drug delivery companies.

Top 22 Injectable Drug Delivery Companies

1. Pharmathen

• Website: pharmathen.com
• Ownership type: Private Equity
• Headquarters: Marousi, North Athens Regional Unit, Greece
• Employee distribution: Greece 96%, Other 4%
• Latest funding: $1.9B, July 2021
• Founded year: 1969
• Headcount: 1001-5000
• LinkedIn: pharmathen

Pharmathen, founded in 1969 and based in Marousi, Greece, is a pharmaceutical company that specializes in innovative drug delivery technologies. The company has established itself as a significant player in the development of advanced pharmaceutical products, particularly focusing on long-acting injectables, sustained release formulations, and ophthalmic products. Pharmathen operates globally, serving pharmaceutical companies and healthcare providers with a commitment to improving patient compliance and healthcare outcomes. With a strong emphasis on research and development, Pharmathen boasts a pipeline of over 40 products and a portfolio of more than 90 commercialized products, which are marketed to 250 customers across over 90 countries. The company invests approximately €35 million annually in R&D, positioning itself among the top pharmaceutical research companies in Europe. Pharmathen's manufacturing capabilities are supported by state-of-the-art facilities that are FDA and EU approved, allowing them to produce a wide range of injectable products, including sterile vials and ampoules. Their focus on innovative technologies, such as biodegradable microparticles and preservative-free ophthalmic formulations, further highlights their commitment to advancing drug delivery solutions.

2. Nemera

• Website: nemera.net
• Ownership type: Private Equity
• Headquarters: Fontaines-Sur-Saône, Auvergne-Rhône-Alpes, France
• Employee distribution: France 61%, United States (USA) 19%, Brazil 10%, Other 11%
• Latest funding: October 2018
• Founded year: 2015
• Headcount: 1001-5000
• LinkedIn: nemera

Nemera, founded in 2015 and based in Fontaines-Sur-Saône, France, is a private equity-backed medical device manufacturer. The company specializes in drug delivery device solutions and combination product services, catering to the pharmaceutical, biotechnology, and generic industries. With a workforce of approximately 1,390 employees, Nemera operates globally, with a significant presence in France, the United States, Brazil, Germany, and Poland. Their offerings include device development, clinical manufacturing, and innovation support, all aimed at maximizing treatment efficacy and ensuring safe medication delivery. Nemera's product portfolio includes various drug delivery systems, particularly in the injectable category, which underscores their commitment to improving healthcare outcomes. They actively engage in partnerships to enhance device strategies and accelerate the delivery of drugs to patients.

3. Antares Pharma Inc.

• Website: antarespharma.com
• Ownership type: Corporate
• Headquarters: Ewing Township, New Jersey, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $960.0M, April 2022
• Founded year: 1979
• Headcount: 51-200
• LinkedIn: antares-pharma-inc-

Antares Pharma Inc. is a biotechnology company based in Ewing Township, New Jersey, founded in 1979. The company focuses on innovative drug delivery technologies and pharmaceutical products aimed at improving patient experiences. Their flagship technology, ENHANZE®, facilitates rapid subcutaneous delivery of drugs, significantly reducing the time required for treatment compared to traditional intravenous methods. Antares Pharma collaborates with various pharmaceutical companies and healthcare providers to enhance treatment protocols and patient outcomes. The company has successfully commercialized two FDA-approved products, HYLENEX® and XYOSTED®, which leverage their advanced drug delivery technologies. In April 2022, Antares Pharma secured $960 million in funding, underscoring its active role in the industry and commitment to developing effective drug delivery solutions.

4. Phillips Medisize

• Website: phillipsmedisize.com
• Ownership type: Corporate
• Headquarters: Hudson, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 56%, Denmark 12%, Mexico 6%, Other 26%
• Latest funding: August 2016
• Founded year: 1964
• Headcount: 5001-10000
• LinkedIn: phillips-medisize

Phillips Medisize, founded in 1964 and based in Hudson, Wisconsin, is a medical device manufacturer that specializes in advanced drug delivery solutions and medical technologies. The company serves pharmaceutical and biotech clients by providing comprehensive design, development, and manufacturing services. Their product offerings include autoinjectors, pen injectors, and wearable diagnostics, all aimed at improving patient care and treatment outcomes. Phillips Medisize operates under strict regulatory compliance, ensuring that their products meet the necessary quality and safety standards. They have a global presence, with facilities in multiple countries, and are recognized for their innovative approach to drug delivery devices, including their award-winning Aria Smart Autoinjector. Their collaboration with major pharmaceutical companies further solidifies their role in the injectable drug delivery market.

5. GP-Pharm

• Website: gp-pharm.com
• Ownership type: Private
• Headquarters: L'Hospitalet De Llobregat, Catalonia, Spain
• Employee distribution: Spain 53%, Argentina 45%, Uruguay 3%
• Founded year: 2000
• Headcount: 51-200
• LinkedIn: lab.-gp-pharm

GP-Pharm is a private pharmaceutical company based in L'Hospitalet De Llobregat, Catalonia, Spain, founded in 2000. The company specializes in the development and manufacturing of injectable drugs, with a particular emphasis on oncology, urology, and women's health. GP-Pharm is known for its expertise in advanced drug delivery systems, including microencapsulation technologies such as liposomes, nanoparticles, and microspheres. They offer comprehensive services that span from research and development to contract manufacturing, catering to both their own product lines and third-party clients. The company has established a strong presence in international markets through strategic partnerships and collaborations with other pharmaceutical firms. Their facilities have been approved by various regulatory agencies, enhancing their credibility and operational capacity. GP-Pharm is committed to continuous innovation and sustainability, investing in both technology and talent to drive their mission forward.

6. Nanomi

• Website: nanomi.com
• Ownership type: Private
• Headquarters: Oldenzaal, Overijssel, Netherlands
• Employee distribution: Netherlands 100%
• Founded year: 2004
• Headcount: 11-50
• LinkedIn: nanomi

Nanomi is a pharmaceutical company based in Oldenzaal, Netherlands, founded in 2004. The company specializes in developing drug delivery systems, particularly long-acting release injectable medicines. Utilizing their proprietary Microsieve technology, Nanomi produces well-defined microspheres and nanoparticles that cater to the needs of pharmaceutical companies and healthcare providers. Their focus on innovation and quality ensures that their products enhance patient compliance and improve therapeutic outcomes. As a subsidiary of Lupin Limited, Nanomi operates within a larger framework that supports its research and development efforts. The company has established itself as a center of excellence in the field of complex injectables, emphasizing the importance of collaboration and partnerships in advancing drug delivery technologies.

7. ForDoz Pharma Corp

• Website: fordozpharma.com
• Ownership type: Private
• Headquarters: East Windsor, New Jersey, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: fordoz-pharma-corp

ForDoz Pharma Corp, based in East Windsor, New Jersey, is a private pharmaceutical company founded in 2014. The firm focuses on developing, manufacturing, and commercializing complex injectable products aimed at treating severe and chronic diseases. Their product portfolio includes the recently FDA-approved Doxorubicin Hydrochloride Liposome Injection, which they launched in August 2024. ForDoz employs proprietary particle-based drug delivery technology, which allows them to create innovative solutions for patients with significant medical needs. The company operates a state-of-the-art cGMP sterile manufacturing facility, ensuring high-quality production standards. In addition to their own products, ForDoz offers Contract Development and Manufacturing Organization (CDMO) services, assisting other pharmaceutical companies in developing and manufacturing complex injectables. Their integrated approach combines research and development, manufacturing, and commercialization, positioning them as a notable player in the injectable drug delivery market.

8. InnoCore Pharmaceuticals

• Website: innocorepharma.com
• Ownership type: Private
• Headquarters: Groningen, Groningen, Netherlands
• Employee distribution: Netherlands 100%
• Latest funding: Other (Grant), January 2021
• Founded year: 2003
• Headcount: 11-50
• LinkedIn: innocore-technologies

InnoCore Pharmaceuticals, founded in 2003 and based in Groningen, Netherlands, is a private pharmaceutical company that specializes in drug delivery technologies. The firm is dedicated to developing injectable sustained release products aimed at treating chronic diseases. Utilizing proprietary platforms like SynBiosys® and LiQuidPolymer™, InnoCore creates biodegradable solutions that allow for controlled and prolonged release of therapeutic compounds, including small molecules, peptides, and proteins. Their technology is particularly significant in addressing the challenges of formulating large biological active pharmaceutical ingredients, which can be difficult to deliver effectively. InnoCore has established partnerships with various biomedical and pharmaceutical companies, showcasing their commitment to innovation in drug delivery. Their collaboration with Merck KGaA further emphasizes their role in enhancing patient compliance and drug efficacy through advanced drug delivery systems. InnoCore's capabilities include research and development, as well as GMP manufacturing, ensuring that they can support clients throughout the product development process.

9. SHL Medical

• Website: shl-medical.com
• Ownership type: Private Equity
• Headquarters: Zug, Zug, Switzerland
• Employee distribution: Taiwan 54%, Switzerland 21%, United States (USA) 19%, Other 6%
• Latest funding: December 2022
• Founded year: 1989
• Headcount: 5001-10000
• LinkedIn: shl-group-scandianvian-health-limited-

SHL Medical, founded in 1989 and based in Zug, Switzerland, is a prominent manufacturer of medical devices that specialize in advanced drug delivery solutions. The company designs and produces a range of devices, including autoinjectors and pen injectors, tailored for pharmaceutical and biotech companies. With a workforce of approximately 1,926 employees, SHL Medical operates globally, with significant facilities in Taiwan, Switzerland, the United States, Sweden, and other locations. Their comprehensive in-house manufacturing capabilities allow for stringent quality control and efficient production processes. SHL Medical is dedicated to enhancing patient independence through self-injection systems and has developed a reputation for innovation in the industry, having received multiple awards for their pioneering technologies. Their product offerings include both disposable and reusable devices, which can be customized to meet specific client needs, including high drug viscosities and connectivity features.

10. Nemaura Pharma Limited

• Website: nemaura.co.uk
• Ownership type: Private
• Headquarters: Loughborough, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Latest funding: $5.0M, February 2017
• Founded year: 2005
• Headcount: 11-50
• LinkedIn: nemaura-pharma-limited

Nemaura Pharma Limited, based in Loughborough, England, is a private pharmaceutical company founded in 2005. The company specializes in advanced drug delivery technologies, particularly focusing on innovative solutions such as injector devices and transdermal systems. Their offerings are designed to enhance patient compliance and improve drug efficacy, catering to healthcare providers and pharmaceutical companies. Nemaura Pharma has developed a range of technologies, including a micro-patch injector that facilitates the delivery of vaccines and potent drugs with minimal pain. They have a robust pipeline and have received funding of £5 million in 2017, which supports their ongoing research and development efforts. With over 80 patents covering multiple technology platforms globally, Nemaura Pharma is positioned to make significant contributions to the field of drug delivery.

11. Biograil

• Website: biograil.com
• Ownership type: Venture Capital
• Headquarters: Roskilde, Denmark
• Employee distribution: Denmark 100%
• Latest funding: Seed, October 2022
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: biograil

Biograil, founded in 2019 and based in Roskilde, Denmark, is a pharmaceutical company that specializes in innovative drug delivery systems. The company leverages its proprietary BIONDD™ technology to convert injectable medications into oral capsules, which enhances patient compliance and treatment efficacy. Biograil primarily serves pharmaceutical companies and healthcare providers looking for effective solutions for biologic drug delivery. The company is currently in the pre-clinical stage and has established strategic partnerships with notable pharmaceutical firms, indicating its potential impact on the market. Biograil has also received seed funding to support its research and development efforts, positioning itself as a promising player in the drug delivery industry.

12. Haselmeier, a medmix Brand

• Website: haselmeier.com
• Ownership type: Corporate
• Headquarters: Stuttgart, Baden-Württemberg, Germany
• Employee distribution: Germany 70%, India 19%, Czech Republic 11%
• Latest funding: $118.0M, August 2020
• Founded year: 1920
• Headcount: 51-200
• LinkedIn: haselmeier-a-medmix-brand

Haselmeier, a medmix Brand, is a medical device manufacturer based in Stuttgart, Germany, with a focus on customized drug delivery solutions for the pharmaceutical and biotechnology sectors. Founded in 1920, the company has a long-standing history in the industry. Haselmeier specializes in developing injection pens and offers comprehensive support services for clinical trials and pharmaceutical manufacturing. Their products aim to improve therapy efficiency and compliance for patients who require self-administration of medications. The company has a significant presence in areas such as diabetes management, oncology, and osteoporosis treatment. With a workforce of around 54 employees, Haselmeier is actively engaged in advancing drug delivery technologies, including connected solutions that enhance patient engagement and data management. In 2020, they secured funding amounting to €118 million, which underscores their growth potential and commitment to innovation in the injectable drug delivery market.

13. Portal Instruments

• Website: portalinstruments.com
• Ownership type: Venture Capital
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $7.0M, April 2022
• Founded year: 2012
• Headcount: 11-50
• LinkedIn: portal-instruments

Portal Instruments, founded in 2012 and based in Cambridge, Massachusetts, is a medical device company focused on revolutionizing drug delivery through its innovative needle-free injection technology. The company aims to enhance the administration of biologic therapies, particularly for patients with chronic diseases, by providing a solution that alleviates the anxiety and discomfort often associated with traditional needle injections. Their technology allows for the delivery of high-viscosity biologics quickly and painlessly, which could significantly improve patient adherence to treatment regimens. Portal Instruments has received funding, with their last round amounting to nearly $7 million in April 2022, indicating investor confidence in their potential. The company is actively seeking partnerships with biopharmaceutical firms to bring their needle-free platform to market, demonstrating their commitment to collaboration and innovation in the injectable drug delivery sector.

14. Abon Pharmaceuticals, LLC

• Website: abonpharma.com
• Ownership type: Private
• Headquarters: Chestnut Ridge, New York, United States (USA)
• Employee distribution: United States (USA) 89%, United Kingdom (UK) 5%, Portugal 5%
• Founded year: 2009
• Headcount: 11-50
• LinkedIn: abon-pharmaceuticals-llc

Abon Pharmaceuticals, LLC, founded in 2009 and based in Chestnut Ridge, New York, is a private pharmaceutical company that specializes in the development of complex generics and proprietary products. The company is particularly focused on drug delivery research and manufacturing, offering a range of injectable and oral dosage forms. Abon serves healthcare providers and pharmaceutical companies, aiming to provide innovative drug solutions that enhance patient compliance and product quality. Their research and development efforts are supported by a highly qualified team of scientists with a proven track record in dosage forms, resulting in multiple patents. Abon has made significant strides in the injectable drug delivery space, with recent FDA approvals for products like Clofarabine Injection and ongoing projects in long-acting injectables. Their commitment to scientific rigor and modern technology positions them as a notable player in the pharmaceutical industry.

15. Naprod Life Sciences Pvt. Ltd.

• Website: naprodgroup.com
• Ownership type: Private
• Headquarters: Mumbai, Maharashtra, India
• Employee distribution: India 100%
• Founded year: 1990
• Headcount: 501-1000
• LinkedIn: naprod-life-sciences

Naprod Life Sciences Pvt. Ltd., founded in 1990 and based in Mumbai, India, is a pharmaceutical manufacturer with a focus on oncology and anesthesia products. The company is dedicated to producing high-quality injectable medications and active pharmaceutical ingredients. With a workforce of approximately 441 employees, Naprod has established itself as a significant player in the pharmaceutical industry, particularly in niche segments. Their manufacturing facility is equipped to produce both liquid and lyophilized injectables, meeting global regulatory standards. Naprod's commitment to innovation is evident in their ongoing research and development efforts aimed at improving drug delivery systems and manufacturing processes. They have built a reputation for providing affordable access to essential medicines, catering to healthcare providers and institutions worldwide. Their extensive product portfolio includes over 500 items, with a strong emphasis on oncology injectables, which are crucial for treating serious medical conditions. Naprod's dedication to quality and compliance has earned them numerous accreditations from respected global bodies, reinforcing their position in the pharmaceutical market.

16. NAL Pharma/IA Capital

• Website: nalpharma.com
• Ownership type: Private
• Headquarters: Hong Kong S.A.R
• Founded year: 2006
• Headcount: 51-200
• LinkedIn: nal-pharma-ia-capital

NAL Pharma, based in Hong Kong, is a biopharmaceutical company founded in 2006. The firm specializes in developing proprietary drug delivery systems and novel dosage forms, particularly in the injectable category. NAL Pharma's technology portfolio includes Bio-NN, which utilizes nanoparticle controlled-release systems for injectable drugs, and Bio-MM, which focuses on extended-release microsphere injections. The company collaborates with various pharmaceutical firms to enhance drug delivery mechanisms, aiming to improve patient compliance and treatment outcomes across therapeutic areas such as oncology, pain management, and central nervous system disorders. NAL Pharma actively seeks partnerships for the commercialization of its products, indicating a strategic approach to market entry and expansion.

17. Enable Injections, Inc.

• Website: enableinjections.com
• Ownership type: Venture Capital
• Headquarters: Cincinnati, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series C, $215.0M, January 2022
• Founded year: 2010
• Headcount: 51-200
• LinkedIn: enable-injections-llc

Enable Injections, Inc., founded in 2010 and based in Cincinnati, Ohio, is a medical device manufacturer that focuses on innovative drug delivery systems. The company is known for its flagship product, the enFuse® platform, which offers a user-friendly and flexible solution for administering medications. This platform is designed to enhance the experience for both patients and healthcare providers, allowing for various administration settings, including at-home self-administration. Enable Injections has made significant strides in the industry, having received FDA approval for its technology, which is now in use with specific drugs. The company operates with a workforce of approximately 189 employees and has attracted substantial venture capital funding, including a notable $215 million in its latest financing round in January 2022. Their commitment to quality and innovation is evident in their focus on human factors and user convenience, ensuring that their products meet the needs of patients and healthcare professionals alike.

18. DelSiTech Ltd

• Website: delsitech.com
• Ownership type: Venture Capital
• Headquarters: Turku, Southwest Finland, Finland
• Employee distribution: Finland 100%
• Latest funding: $10.9M, January 2024
• Founded year: 2001
• Headcount: 11-50
• LinkedIn: delsitech-ltd

DelSiTech Ltd, based in Turku, Finland, is a biotechnology firm that specializes in advanced drug delivery technologies. Founded in 2001, the company has carved out a niche in developing biodegradable silica-based solutions aimed at controlled drug release. Their expertise is particularly evident in the areas of long-acting injectables and ocular drug delivery systems, addressing significant challenges in patient compliance and therapeutic efficacy. DelSiTech collaborates with various pharmaceutical and biotech companies, including AstraZeneca and Bayer Pharma AG, to enhance drug delivery methods. The company is also actively developing its own pipeline of products to meet unmet clinical needs. Recently, DelSiTech secured over 10 million euros in funding in January 2024, indicating strong investor confidence and a commitment to advancing their innovative technologies.

19. Infallible Pharma

• Website: infalliblepharma.com
• Ownership type: Private
• Headquarters: Richmond, Texas, United States (USA)
• Employee distribution: India 100%
• Founded year: 2006
• Headcount: 1-10
• LinkedIn: infallible-pharma

Infallible Pharma, founded in 2006 and based in Richmond, Texas, is a private pharmaceutical manufacturer that specializes in injectable drugs and healthcare products. The company serves hospitals and healthcare institutions, providing essential medications that are crucial for patient care. With a strong commitment to quality and accessibility, Infallible Pharma aims to enhance healthcare delivery across various regions. They have manufacturing units that are accredited by WHO-GMP, indicating adherence to international quality standards. The company is actively expanding its market presence, particularly in critical care injectables, and is pursuing international regulatory approvals to broaden its reach. Infallible Pharma's product range includes a variety of pharmaceutical injections and infusions, catering to the needs of healthcare facilities. Their focus on quality control and compliance underscores their dedication to delivering safe and effective medications.

20. Windgap Medical, Inc.

• Website: windgapmedical.com
• Ownership type: Venture Capital
• Headquarters: Watertown, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, January 2022
• Founded year: 2011
• Headcount: 11-50
• LinkedIn: windgap-medical-inc-

Windgap Medical, Inc. is a medical device manufacturer based in Watertown, Massachusetts, founded in 2011. The company focuses on creating innovative drug delivery solutions, particularly through its autoinjector products. These devices are designed to simplify the administration of complex injectables, addressing challenges such as mixing and dosing difficulties, portability, and ease of use. Windgap Medical collaborates with pharmaceutical companies to develop effective and user-friendly drug delivery systems. The company has achieved over 100 patents and has received more than 30 regulatory approvals for its drug and device combination products. Windgap Medical's commitment to improving patient care and enhancing the drug delivery experience positions it as a notable player in the injectable drug delivery industry.

21. Oakwood Labs

• Website: oakwoodlabs.com
• Ownership type: Private
• Headquarters: Oakwood, Ohio, United States (USA)
• Employee distribution: United States (USA) 98%, Canada 2%
• Founded year: 1997
• Headcount: 51-200
• LinkedIn: oakwood-laboratories

Oakwood Labs, founded in 1997 and based in Oakwood, Ohio, is a pharmaceutical development company that specializes in sustained release injectable products. The company employs its proprietary Chroniject™ technology, which allows for tailored release profiles of injectable drugs, making it suitable for various therapeutic applications including oncology, CNS disorders, and more. Oakwood Labs operates both a research and development facility and an FDA-approved GMP manufacturing facility, enabling them to provide end-to-end solutions for their clients. They have a proven track record of successfully scaling up formulations from lab to commercial production, and they have collaborated with numerous pharmaceutical companies to bring innovative drug delivery solutions to market. With over 25 years of experience in drug encapsulation, Oakwood Labs has established itself as a reliable partner in the injectable drug delivery space.

22. altaviz, llc

• Website: altaviz.com
• Ownership type: Private
• Headquarters: Irvine, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 11-50
• LinkedIn: altaviz-llc

Altaviz, LLC, founded in 2012 and based in Irvine, California, is a private medical device manufacturer focused on creating innovative drug delivery solutions. The company has developed a range of products, including the MVI Platform, which is recognized as the world's first handheld injection platform capable of delivering fluids of varying viscosities with precision. Altaviz's clientele includes both startups and established pharmaceutical companies, highlighting their role in advancing medical practices through technology. Their expertise extends to various applications, such as gene therapies, dermal fillers, and implant delivery systems. Altaviz is committed to improving patient outcomes and enhancing the efficiency of medical procedures through their cutting-edge devices and frameworks.

Injectable Drug Delivery Insights: Key Companies

Want to Find More Injectable Drug Delivery Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!